Clinical trial recruitment in the United States is under structural pressure. Despite record research and development … How Digital Marketing Can Fix Clinical Trial Recruitment ProblemsRead more
Strategy & Execution
How-tos, frameworks, omnichannel planning, and marketing roadmaps.
Why Pharma Companies Struggle With Trial Participant Retention
Nearly 30 percent of clinical trial participants withdraw before study completion in certain therapeutic areas, according … Why Pharma Companies Struggle With Trial Participant RetentionRead more
The Role of Marketing in Accelerating Clinical Trial Enrollment
A pivotal oncology trial enrolling 600 patients across 80 U.S. sites can burn through millions of … The Role of Marketing in Accelerating Clinical Trial EnrollmentRead more
How Lack of Patient-Centricity Hurts Clinical Trial Outcomes
In 2023, the FDA’s Center for Drug Evaluation and Research approved 55 novel drugs, continuing a … How Lack of Patient-Centricity Hurts Clinical Trial OutcomesRead more
Top Clinical Trial Challenges No One in Pharma Talks About
The U.S. pharmaceutical industry invests heavily in marketing, with estimates from Statista showing that spending on … Top Clinical Trial Challenges No One in Pharma Talks AboutRead more
Why Phase II Clinical Trials Are the Graveyard of Drug Development
Nearly 60 percent of drug candidates that enter Phase II clinical trials never advance to Phase … Why Phase II Clinical Trials Are the Graveyard of Drug DevelopmentRead more
What Happens When Pharma Ignores Real-World Evidence
In 2023, nearly half of drugs approved by the U.S. Food and Drug Administration faced post-launch … What Happens When Pharma Ignores Real-World EvidenceRead more
Common Clinical Trial Mistakes Pharma Companies Keep Repeating
Despite decades of regulatory guidance, expanded access to data, and repeated public postmortems of failed programs, … Common Clinical Trial Mistakes Pharma Companies Keep RepeatingRead more
How Misaligned R&D and Marketing Delay Drug Approvals in the U.S. Pharmaceutical Market
In the United States, drug approval timelines are becoming harder to predict. Despite record investment in … How Misaligned R&D and Marketing Delay Drug Approvals in the U.S. Pharmaceutical MarketRead more
Why Great Science Often Fails Commercially in Pharma
In the United States, bringing a new drug to market now costs more than $2 billion on average … Why Great Science Often Fails Commercially in PharmaRead more